The enhanced tumorous Hsp90α/β expression promotes the activation of numerous cancer-critical signal pathways in CRC, which results in tumor growth, modulation of the tumor microenvironment, invasion, metastasis, and drug resistance (e.g., [22,53,54]). This evidence concerns the gene HSP90AA1 and colorectal carcinoma.